Once-daily pefloxacin + teicoplanin vs netilmicin + teicoplanin in empirical therapy for fever and neutropenia.
Studená
M
M
Postgraduate Medical School, Bratislava, Slovak Republic.
Hlavácová
E
E
Helpianska
L
L
Spanik
S
S
Lacka
J
J
Kukucková
E
E
Kollár
T
T
Sálek
T
T
Sufliarsky
J
J
Trupl
J
J
D000328:Adult; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D005839:Gentamicins / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications; D009428:Netilmicin / Q000493:pharmacokinetics / Q000627:therapeutic use; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D015366:Pefloxacin / Q000493:pharmacokinetics / Q000627:therapeutic use; D017334:Teicoplanin / Q000493:pharmacokinetics / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D005839:Gentamicins; D015366:Pefloxacin; D009428:Netilmicin; D017334:Teicoplanin